Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53

Cancer Research

Volumn 61, Issue 5, 2001, Pages 1839-1842

  Ramos, Y F M ^a   Stad, R ^a   Attema, J ^a   Peltenburg, L T C ^a   Van der Eb, A J ^a   Jochemsen, A G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HDMX PROTEIN; PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION FUNCTION; GENE AMPLIFICATION; GLIOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; TUMOR CELL LINE;

FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035266128     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. MDMX: A novel p53-binding protein with some functional properties of MDM2
2. Isolation and identification of the human homolog of a new p53-binding protein, Mdmx
3. Comparative study of the p53-mdm2 and p53-MDMX interfaces
4. Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein
5. MDMX protects p53 from MDM2-mediated degradation
6. Hdmx stabilizes Mdm2 and p53
7. MDM2 function
8. Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification
9. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression
10. c-myc down-regulates class I HLA expression in human melanomas
11. Sensitivity of melanoma cell lines to natural killer cells: A role for oncogenemodulated HLA class I expression?
12. Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: Growth features and cytogenetics
13. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes
14. Chromosome 1 abnormalities in cervical carcinoma
15. Chromosome abnormalities in human epithelial ovarian malignancies
16. Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas
17. Chromosome changes in metastatic human melanoma
18. Malignant melanoma of soft parts. Further cytogenetic characterization
19. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization
20. p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis
21. A novel MDMX transcript expressed in a variety of transformed cell lines encodes a truncated protein with potent p53 repressive activity
22. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: Transforming ability and frequent detection in human cancer
23. Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms
24. Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein in human glioblastoma cells
25. Distinct modulation of p53 activity in transcription and cell-cycle regulation by the large (54 kDa) and small (21 kDa) adenovirus E1B proteins